PharmaTech product directory now live

Arsalan Arif, Fierce Life Sciences publisherAt Fierce, our mission is to be the first place you turn for timely news and resources in the world of drug development. In our constant pursuit of that goal, I'm excited to announce a new product directory partnership (powered by Jaz'd Markets) that connects Fierce readers involved in purchasing pharmaceutical technology products with sellers in new and innovative ways.

Click here to visit our joint partnership: FierceMarketplace PharmaTech.

The guiding principle of the directory is simple: make it useful for buyers. FierceMarketplace: PharmaTech is designed to provide a comprehensive side-by-side review of vendors and products (such as chemical ingredients and protein purification). Best of all, the directory offers one-click "Get-a-Quote" functionality so readers spend less time searching the web and calling suppliers.

This partnership builds on a big growth year for Fierce. As a daily reader, you've had a front row seat to our expansion this year, from the launch of FiercePharma Manufacturing and FierceBiotech IT to FierceMarketplace: PharmaTech. Thanks to your participation, we now enjoy the largest active daily biopharmaceutical industry readership in the world--over 100,000 unique e-mail readers and 800,000 monthly web page-views reaching every major biopharmaceutical company in the world.

Thanks for being part of the Fierce community. Should you have any feedback or questions, my e-mail address is below.

Arsalan Arif
Publisher, Fierce Life Sciences
Email | Twitter

Suggested Articles

Inovio CEO J. Joseph Kim is undeterred by short sellers and other detractors who doubt his company can shuttle a COVID-19 DNA vaccine to market.

Adding entinostat to hormone therapy did not help patients with HR-positive, HER2-negative breast cancer live longer.

The data add to the evidence in support of the IL-6 drug ahead of a FDA decision to approve it in a rare disease served by Alexion’s Soliris.